Follow
Ileana Montoya Perez
Ileana Montoya Perez
Verified email at utu.fi
Title
Cited by
Cited by
Year
Radiomics and machine learning of multisequence multiparametric prostate MRI: Towards improved non-invasive prostate cancer characterization
J Toivonen, I Montoya Perez, P Movahedi, H Merisaari, M Pesola, ...
PloS one 14 (7), e0217702, 2019
1132019
Novel biparametric MRI and targeted biopsy improves risk stratification in men with a clinical suspicion of prostate cancer (IMPROD Trial)
I Jambor, PJ Boström, P Taimen, K Syvänen, E Kähkönen, M Kallajoki, ...
Journal of Magnetic Resonance Imaging 46 (4), 1089-1095, 2017
1052017
Fitting methods for intravoxel incoherent motion imaging of prostate cancer on region of interest level: Repeatability and gleason score prediction
H Merisaari, P Movahedi, IM Perez, J Toivonen, M Pesola, P Taimen, ...
Magnetic resonance in medicine 77 (3), 1249-1264, 2017
842017
Combined use of prostate-specific antigen density and magnetic resonance imaging for prostate biopsy decision planning: a retrospective multi-institutional study using the …
UG Falagario, I Jambor, A Lantz, O Ettala, A Stabile, P Taimen, HJ Aronen, ...
European urology oncology 4 (6), 971-979, 2021
792021
Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial)
I Jambor, A Kuisma, E Kähkönen, J Kemppainen, H Merisaari, O Eskola, ...
European journal of nuclear medicine and molecular imaging 45, 355-364, 2018
732018
Validation of IMPROD biparametric MRI in men with clinically suspected prostate cancer: a prospective multi-institutional trial
I Jambor, J Verho, O Ettala, J Knaapila, P Taimen, KT Syvänen, ...
PLoS medicine 16 (6), e1002813, 2019
692019
Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using routine clinical prostate multiparametric MRI and decipher genomic score
I Jambor, U Falagario, P Ratnani, IM Perez, K Demir, H Merisaari, ...
Journal of Magnetic Resonance Imaging 51 (4), 1075-1085, 2020
362020
Qualitative and quantitative reporting of a unique biparametric MRI: Towards biparametric MRI‐based nomograms for prediction of prostate biopsy outcome in men with a clinical …
IM Perez, I Jambor, T Kauko, J Verho, O Ettala, U Falagario, H Merisaari, ...
Journal of Magnetic Resonance Imaging 51 (5), 1556-1567, 2020
332020
Prebiopsy IMPROD biparametric magnetic resonance imaging combined with prostate-specific antigen density in the diagnosis of prostate cancer: an external validation study
J Knaapila, I Jambor, IM Perez, O Ettala, P Taimen, J Verho, A Kiviniemi, ...
European Urology Oncology 3 (5), 648-656, 2020
312020
Neoadjuvant chemotherapy does not increase the morbidity of radical cystectomy: a 10-year retrospective nationwide study
AP Salminen, I Koskinen, IM Perez, S Hurme, TJ Murtola, MH Vaarala, ...
European urology oncology 1 (6), 525-530, 2018
262018
Tournament leave-pair-out cross-validation for receiver operating characteristic analysis
I Montoya Perez, A Airola, PJ Boström, I Jambor, T Pahikkala
Statistical Methods in Medical Research 28 (10-11), 2975-2991, 2019
252019
IMPROD biparametric MRI in men with a clinical suspicion of prostate cancer (IMPROD Trial): sensitivity for prostate cancer detection in correlation with whole‐mount …
H Merisaari, I Jambor, O Ettala, PJ Boström, I Montoya Perez, J Verho, ...
Journal of Magnetic Resonance Imaging 50 (5), 1641-1650, 2019
222019
Predicting the need for biopsy to detect clinically significant prostate cancer in patients with a magnetic resonance imaging–detected prostate imaging reporting and data …
M Peters, D Eldred-Evans, P Kurver, UG Falagario, MJ Connor, TT Shah, ...
European urology 82 (5), 559-568, 2022
182022
Added value of systematic biopsy in men with a clinical suspicion of prostate cancer undergoing biparametric MRI-targeted biopsy: multi-institutional external validation study
U Falagario, I Jambor, P Taimen, KT Syvänen, E Kähkönen, H Merisaari, ...
World journal of urology 39, 1879-1887, 2021
172021
Negative predictive value of biparametric prostate magnetic resonance imaging in excluding significant prostate cancer: a pooled data analysis based on clinical data from four …
J Knaapila, I Jambor, O Ettala, P Taimen, J Verho, IM Perez, A Kiviniemi, ...
European Urology Focus 7 (3), 522-531, 2021
172021
Correlation between 18F-1-amino-3-fluorocyclobutane-1-carboxylic acid (18F-fluciclovine) uptake and expression of alanine-serine-cysteine-transporter 2 (ASCT2 …
I Saarinen, I Jambor, M Kim, A Kuisma, J Kemppainen, H Merisaari, ...
EJNMMI research 9, 1-11, 2019
172019
Luminometric label array for quantification and identification of metal ions
S Pihlasalo, I Montoya Perez, N Hollo, E Hokkanen, T Pahikkala, ...
Analytical chemistry 88 (10), 5271-5280, 2016
172016
Stratification of aggressive prostate cancer from indolent disease—Prospective controlled trial utilizing expression of 11 genes in apparently benign tissue
S Alinezhad, RM Väänänen, T Tallgrén, IM Perez, I Jambor, H Aronen, ...
Urologic Oncology: Seminars and Original Investigations 34 (6), 255. e15-255 …, 2016
152016
The Mount Sinai prebiopsy risk calculator for predicting any prostate cancer and clinically significant prostate cancer: development of a risk predictive tool and validation …
S Parekh, P Ratnani, U Falagario, D Lundon, D Kewlani, J Nasri, Z Dovey, ...
European urology open science 41, 45-54, 2022
142022
Detection of prostate cancer using biparametric prostate MRI, radiomics, and kallikreins: a retrospective multicenter study of men with a clinical suspicion of prostate cancer
I Montoya Perez, H Merisaari, I Jambor, O Ettala, P Taimen, J Knaapila, ...
Journal of Magnetic Resonance Imaging 55 (2), 465-477, 2022
132022
The system can't perform the operation now. Try again later.
Articles 1–20